La maladie de Crohn (MC) et la rectocolite hémorragique (RCH) sont les deux principales formes cliniques des maladies inflammatoires chroniques de l’intestin (MICI) responsables d’une atteinte inflammatoire de la paroi du tube digestif avec des ulcérations extensives. Ce sont des maladies fréquentes en Europe et en Amérique du Nord avec plus de 2.5 millions de malades. Du fait de l’augmentation importante de leur prévalence, de leur morbidité, du retentissement sur la qualité de vie des malades et du coût de leur prise en charge médicale, les MICI sont devenues un problème majeur de santé publique. Au cours de ces maladies, l’inflammation intestinale peut être contrôlée par les traitements médicamenteux ou la chirurgie sans pour autant obtenir de guérison complète et définitive. Bien que leur origine reste mal connue, l’hypothèse actuelle présente les MICI comme des maladies multifactorielles, secondaires à une réponse immunitaire muqueuse anormale dirigée contre la flore intestinale, survenant chez des individus génétiquement prédisposés et entrainant une inflammation intestinale. Le but du travail était d’explorer les mécanismes à l’origine de cette inflammation intestinale associée au développement des MICI en étudiant plus particulièrement certains facteurs environnementaux, moléculaires et microbiens. Nous avons étudiés tout d’abord l’aluminium comme facteur environnemental en démontrant qu’il pouvait participer au développement et à l’aggravation de l’inflammation intestinale sur des modèles de colite chez la souris. Nous avons ensuite étudié un facteur moléculaire important pour l’apoptose des cellules, la caspase-8. Nous avons montré que cette caspase-8 maintenait l’homéostasie intestinale des cellules épithéliales intestinales et que sont absence entraînait une inflammation intestinale ressemblant à la maladie de Crohn. Finalement nous nous sommes intéressés à un facteur microbien, Saccharomyces cerevisiae CNCM I-3856 qui est une levure. Nous avons démontré que cette levure était capable d’induire un effet anti-inflammatoire et analgésique chez l’animal en activant PPARγ dans le colon. Chez l’homme nous avons montré dans une étude randomisée que Saccharomyces cerevisiae CNCM I-3856 réduisait les douleurs abdominales chez les patients atteints du syndrome de l’intestin irritable. En conclusion, l’exploration de ces trois facteurs environnementaux, moléculaires et microbiens permet de mieux comprendre le développement de l’inflammation intestinale. La perspective de ce travail est le développement dans un futur proche des nouvelles thérapeutiques ciblées permettant de lutter contre l’inflammation intestinale. / Crohn's disease (CD) and ulcerative colitis (UC) are the two main clinical forms of chronic inflammatory bowel disease (IBD) responsible for intestinal inflammation with extensive ulceration of the mucosa. These are common diseases in Europe and North America with over 2.5 million patients. Due to the significant increase in their prevalence, their morbidity, the impact on quality of life of patients and the cost of their medical care, IBD has become a major public health problem. In these diseases, intestinal inflammation may be controlled by drug treatment or surgery without obtaining a complete and final cure. Although their origin remains unclear, the current hypothesis presents IBD as multifactorial diseases secondary to an abnormal mucosal immune response directed against the intestinal flora, occurring in genetically predisposed individuals and causing intestinal inflammation. The aim of this work was to explore the mechanisms behind this intestinal inflammation associated with the development of IBD studying some particular environmental, molecular and microbial factors. We studied first the aluminum as an environmental factor and demonstrated that he could participate in the development and exacerbation of intestinal inflammation in models of colitis in mice. We then studied an important factor in molecular cell apoptosis, caspase-8. We have shown that caspase-8 was maintaining intestinal homeostasis in intestinal epithelial cells and that absence of caspase-8 leads to intestinal inflammation mimicking Crohn's disease. Finally we studied a microbial factor, Saccharomyces cerevisiae CNCM I-3856 which is yeast. We demonstrated that this yeast was capable of inducing an anti-inflammatory and analgesic effect in animals by activating PPARgamma in the colon. In humans we have shown in a randomized study that Saccharomyces cerevisiae CNCM I-3856 reduced abdominal pain in patients with irritable bowel syndrome. In conclusion, the exploration of these three environmental molecular and microbial factors helps to better understand the development of intestinal inflammation. The perspective of this work is the development in the near future of new targeted therapies directed against intestinal inflammation.

Blood vessel mimics (BVMs) are simple tissue engineered blood vessel constructs intended for preclinical testing of vascular devices. This thesis developed and implemented methods to characterize two of these components. The first aim of this thesis investigated the effect of cell culture duration and flow conditions on endothelial cell gene expression, especially regarding endothelial-to-mesenchymal transition (EndMT). A trend of decreased endothelial marker gene expression and increased mesenchymal marker gene expression would indicate EndMT. qPCR analysis revealed that increased cell culture duration did not result in EndMT, and in fact increased endothelial marker expression as cell culture duration increased. Disturbed flow conditions decreased endothelial marker and increased mesenchymal marker expression relative to static culture. The second aim of this thesis developed methods to determine cytotoxicity of, and endothelial cell adhesion to, novel BTEAC salt scaffolds. Immunostaining was used to visualize these scaffold effects. The cytotoxicity elution assay showed that BTEAC salt scaffolds were not more cytotoxic than the standard PLGA scaffold. Direct contact assays spanning several timepoints also found that BTEAC salt scaffolds were not more cytotoxic than standard scaffolds but had higher endothelial cell adhesion and coverage than standard scaffolds. Overall, this thesis developed and implemented methods to characterize the endothelial cells used in the BVM model.

No description available.

Huntington disease (HD) is a devastating and fatal neurodegenerative disease. At the moment, no disease modifying therapies are available, with only symptomatic treatment offered to alleviate psychiatric and some types of motor deficits. As a result, many people will continue to suffer and die from this disease. Small molecule therapies have failed to provide benefit in HD, necessitating more complex gene therapy approaches and the identification of less traditional therapeutic targets. A previous study demonstrated that preventing cleavage of the huntingtin (HTT) protein, the protein that when mutated causes HD, by caspase 6 (C6) at amino acid 586 prevents the onset of disease in transgenic HD model mice. This suggests that inhibiting the toxicity initiated by N586 cleavage could be a promising therapeutic strategy, but a safe and specific way to do this in humans has not been identified. General C6 inhibition is not a feasible strategy due to the vital functions it plays throughout life. Thus, the purpose of this study was to investigate whether the C6 cleavage fragment of HTT, N586, is itself a toxic species of HTT or if it initiates a toxic proteolytic pathway in order to identify more viable therapeutic strategies for HD. To accomplish this, we are using novel and highly sensitive immunoprecipitation and flow cytometry (IP-FCM) protein detection assays, specific for the N586 neoepitope of HTT, to evaluate the in vivo persistence of N586 in HD model mice. If N586 is detected, it is likely that it is itself toxic and promoting its degradation may be beneficial. Conversely, if it is not detected, N586 cleavage likely initiates a toxic degradation pathway and promoting its stability may be beneficial. The results of these studies have the potential to define new therapeutic strategies for HD that can be addressed more specifically than generalized C6 inhibition for the prevention of N586-mediated toxicity. The selective targeting of N586 toxicity, either to promote or prevent its degradation depending on our results, would ensure that therapeutic activity is restricted to HTT and reduce the potential for deleterious off-target effects

No description available.

No description available.

No description available.

No description available.

Programmed cell death in animals, plants and protists is in part regulated by a variety of proteases, including cysteine aspartyl proteases, (caspases, paracaspases and metacaspases), cathepsins, subtilisin-like serine proteases, vacuolar processing enzymes and the proteasome. The role of different proteases in the cell death responses of the fungi is however largely unknown. A greater understanding of the fungal cell death machinery may provide new insights into the mechanisms and evolution of PCD and potentially reveal novel targets for a new generation of antifungal drugs. The role of a metacaspase encoding gene, MCA1, in the cell death response of the human pathogen Candida albicans pathogen has been investigated by functional analysis. MCA1 deletion not only alters the sensitivity of cells to a number of cell death stimuli, it also enhances virulence in an insect model. C. albicans shows altered cell and colony morphology on Lee’s medium. Evidence is presented to suggest that these functions appear to be dependent upon active mitochondria. In this study it has also been shown that key caspase substrates may be conserved between humans and the yeasts Saccharomyces cerevisiae and Candida albicans. Many substrates, particularly those which are essential, have retained their caspase cleavage motifs. 14 protease mutants displayed altered activity against caspase 1, 3, 6 or 8 substrates during acetic acid-induced PCD and caspase 1-like activity appeared to be particularly associated with PCD. Using a novel bioinformatic analysis of experimental LC-MS/MS data, changes in the degradation patterns of the proteome (destructome) following acetic acid-induced cell death have been investigated in wild-type yeast. In addition, potential native substrates of the yeast Mca1 have also been identified. The future challenge is to characterise the destructome of different proteases under a range of cell death conditions. In this way it may be possible to identify key components of the cell death machinery and their substrates and so reveal the most promising targets for future therapeutics.

La toxine stable à la chaleur de type b (STb) est une des toxines produites par les souches Enterotoxigenic Escherichia coli (ETEC) impliquée dans le développement de la diarrhée. Une étude antérieure par Goncalves et al. (2009) a démontré que les cellules ayant internalisé la toxine STb démontraient une morphologie qui rappelle l’apoptose. Le changement du potentiel membranaire observé par Goncalves et al. (2009) nous a incité à vérifier la capacité de la toxine STb à induire l’apoptose des cellules HRT-18 et IEC-18 par la voie intrinsèque. Les cellules HRT-18 et IEC-18 ont été traitées avec de la toxine purifiée pour une durée de 24 heures puis ells ont été récoltées et examinées pour des caratéristiques de l’apoptose. L’activation des caspases-9 et -3, mais pas de la caspase-8, a été observée dans les deux lignées cellulaires à l’aide des substrats fluorescents spécifiques pour chaque caspase. L’ADN extrait des cellules HRT-18 et IEC-18 a révélé une fragmentation lorsque migré sur gel d’agarose. La condensation et la fragmentation des noyaux ont été observées en microscopie à fluorescence suite à une coloration de l’ADN au Hoechst 33342. Les indices apoptotiques des cellules HRT-18 et IEC-18 traitées avec des quantités croissantes de STb montrent une dose-réponse pour les deux lignées. L’activation de la caspase-9 est une indication que la voie intrinsèque de l’apoptose est activée dans les cellules HRT-18 et IEC-18. L’absence de l’activation de la caspase-8 démontre que la voie extrinsèque n’est pas impliquée dans la mort cellulaire médiée par STb. / Heat-stable toxin b (STb) is one of the toxins produced by Enterotoxigenic Escherichia coli (ETEC) strains implicated in the development of diarrhea. A previous study conducted by Goncalves et al. (2009) showed that cells having internalized STb toxin demonstrated apoptotic-like morphology. The change in the mitochondrial membrane potential observed by Goncalves et al. (2009) prompted us to verify the ability of STb toxin to induce apoptosis via the intrinsic pathway in HRT-18 and IEC-18 cells. Both cell lines were treated with purified STb toxin for a period of 24 hours, harvested, and examined for apoptotic features. Activation of caspases-9 and -3, but not -8, was observed in HRT-18 and IEC-18 cells as determined with the use of fluorescent substrates specific to each caspase. Extracted DNA revealed DNA laddering when migrated on agarose gels. Nuclear condensation and fragmentation of Hoechst 33342 stained DNA of HRT-18 and IEC-18 cells were visualized by fluorescence microscopy. Apoptotic indexes of HRT-18 and IEC-18 cells treated with increasing amounts of STb toxin revealed dose-dependent responses in both cell lines. The activation of caspase-9 is an indication of the intrinsic pathway being activated in HRT-18 and IEC-18 cells by STb toxin. The lack of caspase-8 activation demonstrates that the extrinsic pathway of apoptosis is not involved in the programmed cell death mediated by STb.